Your browser doesn't support javascript.
loading
The interplay of autophagy and oxidative stress in the pathogenesis and therapy of retinal degenerative diseases.
Chang, Kun-Che; Liu, Pei-Feng; Chang, Chia-Hsuan; Lin, Ying-Cheng; Chen, Yen-Ju; Shu, Chih-Wen.
Affiliation
  • Chang KC; Department of Ophthalmology and Neurobiology, Louis J. Fox Center for Vision Restoration, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Liu PF; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Chang CH; Department of Biomedical Science and Environmental Biology, PhD Program in Life Science, College of Life Science, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Lin YC; Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
  • Chen YJ; Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Shu CW; Institute of BioPharmaceutical Sciences, National Sun Yat-Sen University, No. 70, Lianhai Rd., Gushan Dist., Kaohsiung, 80424, Taiwan.
Cell Biosci ; 12(1): 1, 2022 Jan 03.
Article in En | MEDLINE | ID: mdl-34980273
ABSTRACT
Oxidative stress is mainly caused by intracellular reactive oxygen species (ROS) production, which is highly associated with normal physiological homeostasis and the pathogenesis of diseases, particularly ocular diseases. Autophagy is a self-clearance pathway that removes oxidized cellular components and regulates cellular ROS levels. ROS can modulate autophagy activity through transcriptional and posttranslational mechanisms. Autophagy further triggers transcription factor activation and degrades impaired organelles and proteins to eliminate excessive ROS in cells. Thus, autophagy may play an antioxidant role in protecting ocular cells from oxidative stress. Nevertheless, excessive autophagy may cause autophagic cell death. In this review, we summarize the mechanisms of interaction between ROS and autophagy and their roles in the pathogenesis of several ocular diseases, including glaucoma, age-related macular degeneration (AMD), diabetic retinopathy (DR), and optic nerve atrophy, which are major causes of blindness. The autophagy modulators used to treat ocular diseases are further discussed. The findings of the studies reviewed here might shed light on the development and use of autophagy modulators for the future treatment of ocular diseases.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies Language: En Journal: Cell Biosci Year: 2022 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies Language: En Journal: Cell Biosci Year: 2022 Document type: Article Affiliation country: Estados Unidos